C‐PLAN index as a prognostic factor for patients with previously untreated advanced non‐small cell lung cancer who received combination immunotherapy: A multicenter retrospective study

BACKGROUND: Combination immunotherapy (immune checkpoint inhibitors and cytotoxic anticancer agents) is widely used as first‐line treatment for advanced non‐small cell lung cancer (NSCLC). However, the therapeutic effect of combination immunotherapy has not been fully investigated. C‐reactive protei...

Descripción completa

Detalles Bibliográficos
Autores principales: Sonehara, Kei, Ozawa, Ryota, Hama, Mineyuki, Nozawa, Shuhei, Agatsuma, Toshihiko, Nishie, Kenichi, Kato, Akane, Matsuo, Akemi, Araki, Taisuke, Komatsu, Masamichi, Tateishi, Kazunari, Hanaoka, Masayuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9968595/
https://www.ncbi.nlm.nih.gov/pubmed/36635979
http://dx.doi.org/10.1111/1759-7714.14798

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9968595/
https://www.ncbi.nlm.nih.gov/pubmed/36635979
http://dx.doi.org/10.1111/1759-7714.14798

Ejemplares similares